Tag Archives: benefit design

Specialty Drug

Planning a Specialty Drug Strategy Through 2020

Posted on by John Santilli

Planning a Specialty Drug Strategy Through 2020 – Traditional approaches are not suited to managing the cost of specialty drug therapies By Gregory Judd, CEBS, and Randy Vogenberg, PhD  5/4/2015 (originally published by Society for Human Resource Management (SHRM))   The specialty drug tsunami is picking up strength and is about to come crashing down on […]

Continue reading →
Pharmaceutical, Trends

Pharmaceutical Growth Driven by M&A and Shareholder Value

Posted on by John Santilli
28
Apr

Pharmaceutical Growth Driven by M&A and Shareholder Value – Biologic and Pharmaceutical companies, along with their financial advisors or venture capital partners, have used mergers and acquisitions over the years to create value in order to keep their leading positions in a changing market. The era of pharmaceutical companies relying on blockbusters for their growth […]

Continue reading →
Dr. Randy Vogenberg

Seeking Value: Managing Specialty Medications and Medication Adherence

Posted on by John Santilli

Amid the constant change churning the health care marketplace, employers have the opportunity to use value-based tactics to get more for their health benefits, including pharmaceutical spending that is currently the biggest driver of rising health care costs. That message was echoed by all four speakers at the Alliance Learning Circle on “Doses and Dollars: […]

Continue reading →
Market Intelligence

Tier 2 is Dead!

Posted on by Dr. Randy

It’s not just Health Care Reform that is turning the world of health care upside down. The cost shift to both the employee/consumer is dramatic and having an effect on sales. The old paradigm of success being defined as having Tier 2 access is no longer valid. The out of pocket burden for the employee/consumer […]

Continue reading →
Market Intelligence

Brokers and EBCs React to Market Changes

Posted on by AMI

Major shifts in the health care market, including the increasing adoption of private exchanges, continue to disrupt the health care landscape as we’ve known it. Those benefit managers and advisers who embrace the change ahead and adapt to it will be the ones that are successful, according to Employee Benefit News. Access Market Intelligence’s quarterly […]

Continue reading →
Market Report

Tier 2 is Dead! Consumerism is having an effect on sales.

Posted on by faisal

It’s not just Health Care Reform that is turning the world of health care upside down. The cost shift to both the employee/consumer is dramatic and having an effect on sales.  The old paradigm of success being defined as having Tier 2 access is no longer valid. The out of pocket burden for the employee/consumer […]

Continue reading →